Skip to content

Vacuum biopsy technique in breast cancer

Comparison of post Neoadjuvant chemotherapy vaccum core needle biopsy and surgical pathology in determining of residual tumor in breast cancer patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241204063942N1
Enrollment
20
Registered
2025-11-16
Start date
2023-04-04
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Phase one of the intervention: Breast cancer patient after chemotherapy undergoing ultrasound-guided vacuum biopsy. Intervention 2: Phase two of the intervention: Breast cancer patien

Sponsors

Iranian academic center for education culture and research
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Breast cancer patient Referrals to the specialized clinic of the Jahad Daneshgahi Breast Cancer Research Institute Candidate for neoadjuvant chemotherapy Triple Negative and HER2+ breast cancer subtype The patient has signed the informed consent form

Exclusion criteria

Exclusion criteria: A patient with breast cancer who is a candidate for surgery at the beginning of treatment.

Design outcomes

Primary

MeasureTime frame
Presence of viable breast tumor in pathology. Timepoint: Vacuum is performed 21 days after the end of chemotherapy on the day of surgery - Surgery is performed immediately after vacuum is performed. Method of measurement: Pathology report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHawzhin Sadat Hashemi

Iranian academic center for education culture and research

hashemy1277@yahoo.com+98 21 8867 9402

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026